by bureau Peppr | 22 June, 2020 | News
With our capabilities from our facility in Oss, the Netherlands, we are able to assist AIMM Therapeutics in the development of their groundbreaking clinical phase anti-cancer...
by bureau Peppr | 12 May, 2020 | News
BioConnection B.V. / Oss, The Netherlands BioConnection has sterile drug product production capacity available for COVID-19 programs BioConnection (established in 2005) is an independent CMO (Contract Manufacturing Organization). We have our own facility in Oss, The...
by bureau Peppr | 9 April, 2020 | News
BioConnection B.V. / Oss, The Netherlands / April 9, 2020 BioConnection has sterile production capacity available for the battle against the Covid-19 pandemic BioConnection (established in 2005) is an independent CMO (Contract Manufacturing Organization) in Oss, The...
by bureau Peppr | 1 April, 2020 | News
BioConnection announces that Lava Therapeutics (LAVA), a biotechnology company creating and developing next-generation γδ T cell engaging bispecific antibodies for the treatment of cancer, has selected BioConnection for GMP DP manufacturing. LAVA and BioConnection now...
by bureau Peppr | 18 March, 2020 | News
Oss, The Netherlands, March 18, 2020. BioConnection has taken precautions related to the global outbreak of the Covid-19 virus. To start with; we are currently in full operation and running on-schedule with regard to our planned productions. Our production department...
by bureau Peppr | 8 April, 2019 | News
Oss, The Netherlands, April 8, 2019. BioConnection will invest €12 million in a second, commercial scale, manufacturing line to keep up with the growing customer demand and to ensure its future company growth. BioConnection, Contract Manufacturing Organization (CMO),...
